Institutional Ownership
Amicus Therapeutics Inc
CUSIP 03152W109COMAM6Q1 2026
13D / 13G Filings
62
Schedule 13D/13G on record
Beneficial Filers
16
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
289
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
62 filings · latest Feb 10, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 10, 2026 | Wellington Management Group LLP | 13G/A | 0.4% | 1.37M | SEC |
| 2 | Feb 9, 2026 | William Blair Investment Management, LLC | 13G/A | 3.4% | 10.63M | SEC |
| 3 | Dec 3, 2025 | The Vanguard Group | 13G/A | 10.0% | 30.87M | SEC |
| 4 | Nov 14, 2025 | Avoro Capital Advisors LLC | 13G/A | 4.9% | 15.03M | SEC |
| 5 | Nov 12, 2025 | William Blair Investment Management, LLC | 13G | 5.2% | 15.97M | SEC |
| 6 | Aug 14, 2025 | Perceptive Advisors LLC | 13G/A | 2.4% | 7.41M | SEC |
| 7 | May 15, 2025 | Perceptive Advisors LLC | 13G/A | 7.0% | 21.46M | SEC |
| 8 | May 15, 2025 | Avoro Capital Advisors LLC | 13G/A | 6.7% | 20.50M | SEC |
| 9 | May 9, 2025 | William Blair Investment Management, LLC | 13G/A | 4.9% | 14.78M | SEC |
| 10 | Apr 23, 2025 | Blackrock, Inc. | 13G/A | 7.4% | 22.77M | SEC |
52 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Amicus Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 33.88M | $489.89M |
| 2 | Ubs Group AG | 15.96M | $230.75M |
| 3 | Pentwater Capital Management LP | 14.00M | $202.44M |
| 4 | State Street Corp | 12.89M | $186.45M |
| 5 | Fil Ltd | 12.56M | $181.62M |
| 6 | Goldman Sachs Group Inc | 11.56M | $167.10M |
| 7 | Qube Research & Technologies Ltd | 8.81M | $127.38M |
| 8 | Hbk Investments L P | 8.78M | $127.01M |
| 9 | Geode Capital Management, LLC | 8.54M | $123.45M |
| 10 | O'Connor Alternative Investments LLC | 8.44M | $122.11M |